Clinical Trial

Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases

Name: Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases — clinical trial record (NCT07121777)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LCAR1901

Recruiting

View on ClinicalTrials.gov →

Summary

This is an open label, single-site, dose-escalation study in up to 18 participants with treatment of Refractory Autoimmune Diseases. This study aims to evaluate the safety and efficacy of the treatment with an Anti- CD19/BCMA CAR gene vector injection

Trial Details

NCT Number	NCT07121777
Lead Sponsor	Anhui Provincial Hospital
Conditions	Autoimmune Diseases
Enrollment	18 participants
Start Date	2025-08-25
Primary Completion	2029-08-31 (estimated)
Study Completion	2029-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-08-13